Literature DB >> 24502503

Long-term course of Dravet syndrome: a study from an epilepsy center in Japan.

Rumiko Takayama1, Tateki Fujiwara, Hideo Shigematsu, Katsumi Imai, Yukitoshi Takahashi, Kazuhiro Yamakawa, Yushi Inoue.   

Abstract

OBJECTIVE: This study attempted to clarify the long-term course of Dravet syndrome (DS).
METHODS: Sixty-four patients diagnosed with DS (44 with typical DS, and 20 with atypical DS) were studied. The long-term outcomes of clinical seizures, electroencephalographic findings, neuropsychological findings, and social situation were analyzed. The follow-up period ranged from 11 to 34 years 5 months (median 24 years).
RESULTS: At the last visit, the ages ranged from 19 years to 45 years (median 30 years). Fifty-nine patients continued to have generalized tonic-clonic seizures (GTCS). Status epilepticus and unilateral seizures were not observed and myoclonic seizures, atypical absence seizures, and photosensitive seizures were resolved in most patients. The frequency of complex partial seizures was equally low, with five patients at presentation and six patients at the last visit, respectively. Five patients achieved seizure remission (seizure-free for 1 year or longer). Only 1 of 44 patients with typical DS had seizure remission, whereas 4 of 20 patients with atypical DS remitted, with a statistically significant difference between the two phenotypes (p = 0.03). Intellectual disability was found in all patients; especially, severe intellectual disability was prevalent. Patients with atypical DS tended to have milder intellectual disability compared to those with typical DS (p = 0.0283). Occipital alpha rhythm in the basic activity was associated with milder intellectual disability (p = 0.0085). The freedom from seizures correlated with appearance of occipital alpha rhythms (p = 0.0008) and disappearance of epileptic discharges (p = 0.0004). Two patients with GTCS died. Mutations of the neuronal voltage-gated sodium channel alpha subunit type 1 gene were detected at a high frequency (33 of 36 patients examined). Seizure remission was found only in the missense mutation group. SIGNIFICANCE: The long-term seizure and intellectual outcomes are extremely poor in patients with typical DS compared to those with atypical DS. Epilepsy phenotype may influence long-term course of DS. Wiley Periodicals, Inc.
© 2014 International League Against Epilepsy.

Entities:  

Keywords:  Intractable childhood epilepsy with generalized tonic-clonic seizure; Long-term course; Neuronal voltage-gated sodium channel alpha subunit type 1 gene; Severe myoclonic epilepsy in infancy

Mesh:

Year:  2014        PMID: 24502503     DOI: 10.1111/epi.12532

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  13 in total

Review 1.  Sodium channel β subunits: emerging targets in channelopathies.

Authors:  Heather A O'Malley; Lori L Isom
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

Review 2.  Treatment Strategies for Dravet Syndrome.

Authors:  Kelly G Knupp; Elaine C Wirrell
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

Review 3.  Pharmacotherapy for Dravet Syndrome.

Authors:  Adam Wallace; Elaine Wirrell; Daniel L Kenney-Jung
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

4.  NaV1.1 haploinsufficiency impairs glutamatergic and GABAergic neuron function in the thalamus.

Authors:  Carleigh Studtmann; Marek Ladislav; Mackenzie A Topolski; Mona Safari; Sharon A Swanger
Journal:  Neurobiol Dis       Date:  2022-02-24       Impact factor: 5.996

Review 5.  Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy.

Authors:  Lori L Isom; Kelly G Knupp
Journal:  Neurotherapeutics       Date:  2021-08-10       Impact factor: 6.088

Review 6.  Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome.

Authors:  An-Sofie Schoonjans; Lieven Lagae; Berten Ceulemans
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

7.  Progressive Worsening of Gait and Motor Abnormalities in Older Adults With Dravet Syndrome.

Authors:  Arunan Selvarajah; Carolina Gorodetsky; Paula Marques; Quratulain Zulfiqar Ali; Anne T Berg; Alfonso Fasano; Danielle M Andrade
Journal:  Neurology       Date:  2022-04-13       Impact factor: 11.800

8.  Efficacy of Stiripentol in Dravet Syndrome with or without SCN1A Mutations.

Authors:  Min Jung Cho; Soon Sung Kwon; Ara Ko; Seung Tae Lee; Young Mock Lee; Heung Dong Kim; Hee Jung Chung; Se Hee Kim; Joon Soo Lee; Dae Sung Kim; Hoon Chul Kang
Journal:  J Clin Neurol       Date:  2017-10-31       Impact factor: 3.077

9.  Delayed maturation of GABAergic signaling in the Scn1a and Scn1b mouse models of Dravet Syndrome.

Authors:  Yukun Yuan; Heather A O'Malley; Melissa A Smaldino; Alexandra A Bouza; Jacob M Hull; Lori L Isom
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

Review 10.  A Role for Vasoactive Intestinal Peptide Interneurons in Neurodevelopmental Disorders.

Authors:  Kevin M Goff; Ethan M Goldberg
Journal:  Dev Neurosci       Date:  2021-04-01       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.